Marie-Francoise Chesselet M.D. Ph.D.

BIOGRAPHY

Marie-Françoise Chesselet is the Charles H. Markham Professor of Neurology, distinguished Professor in the Departments of Neurology and Neurobiology, and Interim Chair of the Department of Neurology at UCLA. After receiving the M.D. and Ph.D. degrees in Paris, France, she held research positions in France and faculty positions at the Medical College of Pennsylvania and the University of Pennsylvania, before joining UCLA in 1996. At UCLA, Dr. Chesselet chaired the Department of Neurobiology from 2002 to 2013 and is currently the Director of the Integrative Center for Neural Repair, which includes the Center for the Study of Parkinson’s Disease at UCLA she created in 1998. She has directed the NINDS-funded UCLA UDALL Center for Parkinson’s disease research from 1998 to 2013, the NIEHS-funded UCLA Center for Gene Environment in Parkinson’s Disease from 2002 to 2014, and the UCLA Advanced Center for Parkinson’s Disease Research of the American Parkinson Disease Association since 1998. Dr. Chesselet has directed graduate programs at the University of Pennsylvania and UCLA and has directed the NINDS-funded Training Program in Neural Repair from 1998 to 2014. Her laboratory conducts research on the molecular mechanisms of disorders of the basal ganglia and new treatments for Parkinson’s and Huntington’s diseases. Her work has been extensively supported by the NIH, the Michael J. Fox Foundation, Cure HD Initiative, and several bio pharmaceutical companies. She currently holds grants from the Department of Defense, CIRM, and Tsumura Inc. Dr. Chesselet is a Fellow of the American Association for the Advancement of Science and currently chair its section on Neuroscience. She just completed a 4 years term on the National Advisory Environmental Health Sciences Council.

PUBLICATIONS

Subramaniam Sudhakar Raja, Chesselet Marie-Francoise   Mitochondrial dysfunction and oxidative stress in Parkinson’s disease Progress in neurobiology, 2013; .Chesselet Marie-Francoise, Richter Franziska, Zhu Chunni, Magen Iddo, Watson Melanie B, Subramaniam Sudhakar R   A progressive mouse model of Parkinson’s disease: the Thy1-aSyn (“Line 61”) mice Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2012; 9(2): 297-314.Chesselet Marie-Francoise, Carmichael S Thomas   Animal models of neurological disorders Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2012; 9(2): 241-4.McDowell Kimberly, Chesselet Marie-Françoise   Animal models of the non-motor features of Parkinson’s disease Neurobiology of disease, 2012; 46(3): 597-606.Magen Iddo, Fleming Sheila M, Zhu Chunni, Garcia Eddie C, Cardiff Katherine M, Dinh Diana, De La Rosa Krystal, Sanchez Maria, Torres Eileen Ruth, Masliah Eliezer, Jentsch J David, Chesselet Marie-Françoise   Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease The European journal of neuroscience, 2012; 35(6): 870-82.Hickey Miriam A, Zhu Chunni, Medvedeva Vera, Franich Nicholas R, Levine Michael S, Chesselet Marie-Françoise   Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington’s disease Molecular and cellular neurosciences, 2012; 49(2): 149-57.Hickey Miriam A, Zhu Chunni, Medvedeva Vera, Lerner Renata P, Patassini Stefano, Franich Nicholas R, Maiti Panchanan, Frautschy Sally A, Zeitlin Scott, Levine Michael S, Chesselet Marie-Françoise   Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington’s disease Molecular neurodegeneration, 2012; 7(6): 12.Watson Melanie B, Richter Franziska, Lee Soo Kyung, Gabby Lauryn, Wu Jennifer, Masliah Eliezer, Effros Rita B, Chesselet Marie-Françoise   Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein Experimental neurology, 2012; 237(2): 318-34.Lerner Renata P, Trejo Martinez Luz Del Carmen G, Zhu Chunni, Chesselet Marie-Françoise, Hickey Miriam A   Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington’s disease Brain research bulletin, 2012; 87(6): 571-8.Cabeza-Arvelaiz Yofre, Fleming Sheila M, Richter Franziska, Masliah Eliezer, Chesselet Marie-Francoise, Schiestl Robert H   Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons Molecular neurodegeneration, 2011; 6(2): 83.Lam Hoa A, Wu Nanping, Cely Ingrid, Kelly Rachel L, Hean Sindalana, Richter Franziska, Magen Iddo, Cepeda Carlos, Ackerson Larry C, Walwyn Wendy, Masliah Eliezer, Chesselet Marie-Françoise, Levine Michael S, Maidment Nigel T   Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein Journal of neuroscience research, 2011; 89(7): 1091-102.Chesselet Marie-Françoise, Richter Franziska   Modelling of Parkinson’s disease in mice Lancet neurology, 2011; 10(12): 1108-18.Hutson Che Brown, Lazo Carlos R, Mortazavi Farzad, Giza Christopher C, Hovda David, Chesselet Marie-Francoise   Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat Journal of neurotrauma, 2011; 28(9): 1783-801.Fleming Sheila M, Mulligan Caitlin K, Richter Franziska, Mortazavi Farzad, Lemesre Vincent, Frias Carmen, Zhu Chunni, Stewart Alistair, Gozes Illana, Morimoto Bruce, Chesselet Marie-Françoise   A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions Molecular and cellular neurosciences, 2010; .Magen Iddo, Chesselet Marie-Françoise   Genetic mouse models of Parkinson’s disease The state of the art Progress in brain research, 2010; 184(2): 53-87.De Deurwaerdère Philippe, Le Moine Catherine, Chesselet Marie-Françoise   Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia Neuroscience letters, 2010; 469(2): 251-5.Phan Jack, Hickey Miriam A, Zhang Peixiang, Chesselet Marie-Francoise, Reue Karen   Adipose tissue dysfunction tracks disease progression in two Huntington’s disease mouse models Human molecular genetics, 2009; 18(6): 1006-16.Lu Xiao-Hong, Fleming Sheila M, Meurers Bernhard, Ackerson Larry C, Mortazavi Farzad, Lo Victor, Hernandez Daniela, Sulzer David, Jackson George R, Maidment Nigel T, Chesselet Marie-Francoise, Yang X William   Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009; 29(7): 1962-76.Steele Andrew D, Zhou Zhipeng, Jackson Walker S, Zhu Chunni, Auluck Pavan, Moskowitz Michael A, Chesselet Marie-Francoise, Lindquist Susan   Context dependent neuroprotective properties of prion protein (PrP) Prion, 2009; 3(4): 240-9.Hoang Tuan, Choi Dong-Kug, Nagai Makiko, Wu Du-Chu, Nagata Tetsuya, Prou Delphine, Wilson Glenn L, Vila Miquel, Jackson-Lewis Vernice, Dawson Valina L, Dawson Ted M, Chesselet Marie-Françoise, Przedborski Serge   Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease Free radical biology & medicine, 2009; 47(7): 1049-56.Richter Franziska, Meurers Bernhard H, Zhu Chunni, Medvedeva Vera P, Chesselet Marie-Françoise   Neurons express hemoglobin alpha- and beta-chains in rat and human brains The Journal of comparative neurology, 2009; 515(5): 538-47.Wang Lixin, Fleming Sheila M, Chesselet Marie-Françoise, Taché Yvette   Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein Neuroreport, 2008; 19(8): 873-6.Meredith Gloria E, Sonsalla Patricia K, Chesselet Marie-Francoise   Animal models of Parkinson’s disease progression Acta neuropathologica, 2008; 115(4): 385-98.Reliene Ramune, Fleming Sheila M, Chesselet Marie-Françoise, Schiestl Robert H   Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2008; 46(4): 1371-7.Chesselet Marie-Francoise   In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson’s disease? Experimental neurology, 2008; 209(1): 22-7.Fleming Sheila M, Tetreault Nicole A, Mulligan Caitlin K, Hutson Ché B, Masliah Eliezer, Chesselet Marie-Françoise   Olfactory deficits in mice overexpressing human wildtype alpha-synuclein The European journal of neuroscience, 2008; 28(2): 247-56.Chesselet Marie-Francoise, Fleming Sheila, Mortazavi Farzad, Meurers Bernd   Strengths and limitations of genetic mouse models of Parkinson’s disease Parkinsonism & related disorders, 2008; 14 Suppl 2(1): S84-7.Effros Rita B, Austad Steven, Blau Helen, Chesselet Marie-Francoise, Ingram Donald, Johnson Thomas E, Kaeberlein Matt, Lundblad Vicki, McCarter Roger, McElhaney Janet, Saag Michael   The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America The journals of gerontology. Series A, Biological sciences and medical sciences, 2008; 63(4): 331-7.Chou Arthur P, Maidment Nigel, Klintenberg Rebecka, Casida John E, Li Sharon, Fitzmaurice Arthur G, Fernagut Pierre-Olivier, Mortazavi Farzad, Chesselet Marie-Francoise, Bronstein Jeff M   Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome The Journal of biological chemistry, 2008; 283(50): 34696-703.Chesselet Marie-Françoise, Plotkin Joshua L, Wu Nanping, Levine Michael S   Development of striatal fast-spiking GABAergic interneurons Progress in brain research, 2007; 160(4): 261-72.Litvan Irene, Chesselet Marie-Francoise, Gasser Thomas, Di Monte Donato A, Parker Davis, Hagg Theo, Hardy John, Jenner Peter, Myers Richard H, Price Donald, Hallett Mark, Langston William J, Lang Anthony E, Halliday Glenda, Rocca Walter, Duyckaerts Charles, Dickson Dennis W, Ben-Shlomo Yoav, Goetz Christopher G, Melamed Eldad   The etiopathogenesis of Parkinson disease and suggestions for future research. Part II Journal of neuropathology and experimental neurology, 2007; 66(5): 329-36.Litvan Irene, Halliday Glenda, Hallett Mark, Goetz Christopher G, Rocca Walter, Duyckaerts Charles, Ben-Shlomo Yoav, Dickson Dennis W, Lang Anthony E, Chesselet Marie-Francoise, Langston William J, Di Monte Donato A, Gasser Thomas, Hagg Theo, Hardy John, Jenner Peter, Melamed Eldad, Myers Richard H, Parker Davis, Price Donald L   The etiopathogenesis of Parkinson disease and suggestions for future research. Part I Journal of neuropathology and experimental neurology, 2007; 66(4): 251-7.Fleming Sheila M, Chesselet Marie-Françoise   Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism Behavioural pharmacology, 2006; 17(5-6): 383-91.Dewing Phoebe, Chiang Charleston W K, Sinchak Kevin, Sim Helena, Fernagut Pierre-Olivier, Kelly Sabine, Chesselet Marie-Francoise, Micevych Paul E, Albrecht Kenneth H, Harley Vincent R, Vilain Eric   Direct regulation of adult brain function by the male-specific factor SRY Current biology : CB, 2006; 16(4): 415-20.Riban Veronique, Chesselet Marie-Françoise   Region-specific sprouting of crossed corticofugal fibers after unilateral cortical lesions in adult mice Experimental neurology, 2006; 197(2): 451-7.Hwang Dong-Youn, Fleming Sheila M, Ardayfio Paul, Moran-Gates Taylor, Kim Hansoo, Tarazi Frank I, Chesselet Marie-Francoise, Kim Kwang-Soo   3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson’s disease The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005; 25(8): 2132-7.Chesselet Marie-Françoise   Animal models of neurological disorders NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2005; 2(3): 395.Hickey M A, Gallant K, Gross G G, Levine M S, Chesselet Marie-Françoise   Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing Neurobiology of disease, 2005; 20(1): 1-11.Mehta Arpesh, Chesselet Marie-Françoise   Effect of GABA(A) receptor stimulation in the subthalamic nucleus on motor deficits induced by nigrostriatal lesions in the rat Experimental neurology, 2005; 193(1): 110-7.Vourc’h Patrick, Lacar Benjamin, Mignon Laurence, Lucas Paul A, Young Henry E, Chesselet Marie-Françoise   Effect of neurturin on multipotent cells isolated from the adult skeletal muscle Biochemical and biophysical research communications, 2005; 332(1): 215-23.Plotkin Joshua L, Wu Nanping, Chesselet Marie-Françoise, Levine Michael S   Functional and molecular development of striatal fast-spiking GABAergic interneurons and their cortical inputs The European journal of neuroscience, 2005; 22(5): 1097-108.Fleming Sheila M, Fernagut Pierre-Olivier, Chesselet Marie-Françoise   Genetic mouse models of parkinsonism: strengths and limitations NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2005; 2(3): 495-503.Gotts Jeffrey E, Chesselet Marie-Françoise   Mechanisms of subventricular zone expansion after focal cortical ischemic injury The Journal of comparative neurology, 2005; 488(2): 201-14.Gotts Jeffrey E, Chesselet Marie-Françoise   Migration and fate of newly born cells after focal cortical ischemia in adult rats Journal of neuroscience research, 2005; 80(2): 160-71.Mignon Laurence, Vourc’h Patrick, Romero-Ramos Marina, Osztermann Philip, Young Henry E, Lucas Paul A, Chesselet Marie-Françoise   Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats The Journal of comparative neurology, 2005; 491(2): 96-108.Gotts Jeffrey E, Chesselet Marie-Françoise   Vascular changes in the subventricular zone after distal cortical lesions Experimental neurology, 2005; 194(1): 139-50.Young Henry E, Duplaa Cecile, Romero-Ramos Marina, Chesselet Marie-Francoise, Vourc’h Patrick, Yost Michael J, Ericson Kurt, Terracio Louis, Asahara Takayuki, Masuda Haruchika, Tamura-Ninomiya Sayaka, Detmer Kristina, Bray Robert A, Steele Timothy A, Hixson Douglas, el-Kalay Mohammad, Tobin Brian W, Russ Roy D, Horst Michael N, Floyd Julie A, Henson Nicholas L, Hawkins Kristina C, Groom Jaime, Parikh Amar, Blake Lisa, Bland Laura J, Thompson Angela J, Kirincich Amy, Moreau Catherine, Hudson John, Bowyer Frank P, Lin T J, Black Asa C   Adult reserve stem cells and their potential for tissue engineering Cell biochemistry and biophysics, 2004; 40(1): 1-80.Fernagut Pierre-Olivier, Chesselet Marie-Françoise   Alpha-synuclein and transgenic mouse models Neurobiology of disease, 2004; 17(2): 123-30.Fleming Sheila M, Zhu Chunni, Fernagut Pierre-Olivier, Mehta Arpesh, DiCarlo Cheryl D, Seaman Ronald L, Chesselet Marie-Françoise   Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone Experimental neurology, 2004; 187(2): 418-29.Oberlin Shelley R, Konakova Marina, Pulst Stefan, Chesselet Marie-Françoise   Development and anatomic localization of torsinA Advances in neurology, 2004; 94(1-2): 61-5.Fleming Sheila M, Salcedo Jonathan, Fernagut Pierre-Olivier, Rockenstein Edward, Masliah Eliezer, Levine Michael S, Chesselet Marie-Françoise   Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004; 24(42): 9434-40.Levine Michael S, Cepeda Carlos, Hickey Miriam A, Fleming Sheila M, Chesselet Marie-Françoise   Genetic mouse models of Huntington’s and Parkinson’s diseases: illuminating but imperfect Trends in neurosciences, 2004; 27(11): 691-7.Vourc’h Patrick, Romero-Ramos Marina, Chivatakarn Onanong, Young Henry E, Lucas Paul A, El-Kalay Mohammad, Chesselet Marie-Françoise   Isolation and characterization of cells with neurogenic potential from adult skeletal muscle Biochemical and biophysical research communications, 2004; 317(3): 893-901.Mir Halleh M, Tatsukawa Keith J, Carmichael S Thomas, Chesselet Marie-Francoise, Kornblum Harley I   Metabolic correlates of lesion-specific plasticity: an in vivo imaging study Brain research, 2004; 1002(1-2): 28-34.Zhu Chunni, Vourc’h Patrick, Fernagut Pierre-Olivier, Fleming Sheila M, Lacan Sanja, Dicarlo Cheryl D, Seaman Ronald L, Chesselet Marie-Françoise   Variable effects of chronic subcutaneous administration of rotenone on striatal histology The Journal of comparative neurology, 2004; 478(4): 418-26.Hickey Miriam A, Chesselet Marie Françoise   Apoptosis in Huntington’s disease Progress in neuro-psychopharmacology & biological psychiatry, 2003; 27(2): 255-65.Goldberg Matthew S, Fleming Sheila M, Palacino James J, Cepeda Carlos, Lam Hoa A, Bhatnagar Anushree, Meloni Edward G, Wu Nanping, Ackerson Larry C, Klapstein Gloria J, Gajendiran Mahadevan, Roth Bryan L, Chesselet Marie-Francoise, Maidment Nigel T, Levine Michael S, Shen Jie   Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons The Journal of biological chemistry, 2003; 278(44): 43628-35.Menalled Liliana B, Sison Jessica D, Dragatsis Ioannis, Zeitlin Scott, Chesselet Marie-Françoise   Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington’s disease with 140 CAG repeats The Journal of comparative neurology, 2003; 465(1): 11-26.Toneff Thomas, Mende-Mueller Liane, Wu Ying, Hwang Shin-Rong, Bundey Richard, Thompson Leslie M, Chesselet Marie-Francoise, Hook Vivian   Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain Journal of neurochemistry, 2002; 82(1): 84-92.Menalled Liliana B, Sison Jessica D, Wu Ying, Olivieri Melisa, Li Xiao-Jiang, Li He, Zeitlin Scott, Chesselet Marie-Françoise   Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington’s disease knock-in mice The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002; 22(18): 8266-76.Menalled Liliana B, Chesselet Marie-Françoise   Mouse models of Huntington’s disease Trends in pharmacological sciences, 2002; 23(1): 32-9.Romero-Ramos Marina, Vourc’h Patrick, Young Henry E, Lucas Paul A, Wu Young, Chivatakarn Onanong, Zaman Rumina, Dunkelman Noushin, el-Kalay Mohammad A, Chesselet Marie-Françoise   Neuronal differentiation of stem cells isolated from adult muscle Journal of neuroscience research, 2002; 69(6): 894-907.Carmichael S Thomas, Chesselet Marie-Françoise   Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002; 22(14): 6062-70.McDowell Kimberly A, Shin David, Roos Kenneth P, Chesselet Marie-Françoise   Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein Journal of Parkinson’s disease, 2014; 4(3): 531-9.Richter Franziska, Fleming Sheila M, Watson Melanie, Lemesre Vincent, Pellegrino Lee, Ranes Brian, Zhu Chunni, Mortazavi Farzad, Mulligan Caitlin K, Sioshansi Pedrom C, Hean Sindalana, De La Rosa Krystal, Khanna Richie, Flanagan John, Lockhart David J, Wustman Brandon A, Clark Sean W, Chesselet Marie-Françoise   A GCase chaperone improves motor function in a mouse model of synucleinopathy Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014; 11(4): 840-56.Fleming Sheila M, Jordan Maria C, Mulligan Caitlin K, Masliah Eliezer, Holden John G, Millard Ronald W, Chesselet Marie-Françoise, Roos Kenneth P   Impaired baroreflex function in mice overexpressing alpha-synuclein Frontiers in neurology, 2013; 4(3): 103.Navailles Sylvia, Lagière Mélanie, Roumegous Audrey, Polito Marina, Boujema Méric B, Cador Martine, Dunlop John, Chesselet Marie-Françoise, Millan Mark J, De Deurwaerdère Philippe   Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson’s disease The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2013; 16(3): 593-606.Magen Iddo, Ostritsky Regina, Richter Franziska, Zhu Chunni, Fleming Sheila M, Lemesre Vincent, Stewart Alistair J, Morimoto Bruce H, Gozes Illana, Chesselet Marie-Françoise   Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein Pharmacology research & perspectives, 2014; 2(5): e00065.Magen Iddo, Torres Eileen Ruth, Dinh Diana, Chung Andrew, Masliah Eliezer, Chesselet Marie-Françoise   Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson’s Disease Journal of Parkinson’s disease, 2015; .Magen Iddo, Chesselet Marie-Françoise   Mouse models of cognitive deficits due to alpha-synuclein pathology Journal of Parkinson’s disease, 2011; 1(3): 217-27.Richter Franziska, Gao Fuying, Medvedeva Vera, Lee Patrick, Bove Nicholas, Fleming Sheila M, Michaud Magali, Lemesre Vincent, Patassini Stefano, De La Rosa Krystal, Mulligan Caitlin K, Sioshansi Pedrom C, Zhu Chunni, Coppola Giovanni, Bordet Thierry, Pruss Rebecca M, Chesselet Marie-Françoise   Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons Neurobiology of disease, 2014; 69(5): 263-75.Hatami Asa, Chesselet Marie-Francoise   Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits Current topics in behavioral neurosciences, 2015; 22: 303-30.Grant Laura M, Richter Franziska, Miller Julie E, White Stephanie A, Fox Cynthia M, Zhu Chunni, Chesselet Marie-Francoise, Ciucci Michelle R   Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson’s disease Behavioral neuroscience, 2014; 128(2): 110-21.Subramaniam Sudhakar Raja, Vergnes Laurent, Franich Nicholas R, Reue Karen, Chesselet Marie-Francoise   Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein Neurobiology of disease, 2014; 70: 204-13.